CIBC Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
994
+41
+4% +$18.9K ﹤0.01% 826
2026
Q1
$458K Hold
953
﹤0.01% 827
2025
Q4
$535K Hold
953
﹤0.01% 788
2025
Q3
$490K Hold
953
﹤0.01% 781
2025
Q2
$299K Hold
953
﹤0.01% 901
2025
Q1
$290K Buy
953
+17
+2% +$5.72K ﹤0.01% 882
2024
Q4
$311K Buy
936
+47
+5% +$15.9K ﹤0.01% 871
2024
Q3
$297K Buy
889
+29
+3% +$11K ﹤0.01% 884
2024
Q2
$354K Buy
860
+204
+31% +$80.8K ﹤0.01% 792
2024
Q1
$265K Hold
656
﹤0.01% 877
2023
Q4
$201K Buy
+656
New +$177K ﹤0.01% 1003
2022
Q4
Sell
-1,331
Closed -$209K 1182
2022
Q3
$209K Buy
+1,331
New +$212K ﹤0.01% 1066
2022
Q2
Sell
-1,428
Closed -$234K 1393
2022
Q1
$234K Hold
1,428
﹤0.01% 1234
2021
Q4
$311K Buy
1,428
+35
+3% +$7.33K ﹤0.01% 1053
2021
Q3
$264K Buy
1,393
+96
+7% +$17.5K ﹤0.01% 1104
2021
Q2
$229K Hold
1,297
﹤0.01% 1190
2021
Q1
$213K Buy
+1,297
New +$198K ﹤0.01% 1206

Other funds holding MEDP

CIBC Asset Management's MEDP Position: Q2 2026 in Review

CIBC Asset Management increased its Medpace (MEDP) stake by 4.3% in Q2 2026, buying an estimated $18.9K and bringing the position to 994 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

CIBC Asset Management first reported a position in MEDP in Q1 2021 and has held it in 17 quarters since. The position peaked at $535K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • CIBC Asset Management held 994 shares of Medpace worth $526K as of Q2 2026.
  • CIBC Asset Management bought 41 Medpace shares in Q2 2026, an estimated $18.9K.
  • Medpace made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #826 holding.
  • CIBC Asset Management first reported a position in Medpace in Q1 2021 and has held it in 17 quarters since.
  • CIBC Asset Management's Medpace position peaked at $535K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.